4.7 Article

The pregnane X receptor down-regulates organic cation transporter 1 (SLC22A1) in human hepatocytes by competing for (squelching) SRC-1 coactivator

期刊

BRITISH JOURNAL OF PHARMACOLOGY
卷 173, 期 10, 页码 1703-1715

出版社

WILEY-BLACKWELL
DOI: 10.1111/bph.13472

关键词

-

资金

  1. Czech Scientific Agency [GACR 303/12/G163]
  2. SVV project [260 293]

向作者/读者索取更多资源

Background and PurposeThe organic cation transporter 1 (OCT1) transports cationic drugs into hepatocytes. The high hepatic expression of OCT1 is controlled by the HNF4 and USF transcription factors. Pregnane X receptor (PXR) mediates induction of the principal xenobiotic metabolizing enzymes and transporters in the liver. Here, we have assessed the down-regulation of OCT1 expression by PXR activation. Experimental ApproachWe used primary human hepatocytes and related cell lines to measure OCT1 expression and activity, by assaying MPP+ accumulation. Western blotting, qRT-PCR, the OCT1 promoter gene reporter constructs and chromatin immunoprecipitation assays were also used. Key ResultsOCT1 mRNA in human hepatocytes was down-regulated along with reduced [H-3]MPP+ accumulation in differentiated HepaRG cells after treatment with rifampicin. Rifampicin and hyperforin as well as the constitutively active PXR mutant T248D suppressed activity of the 1.8kb OCT1 promoter construct in gene reporter assays. Silencing of both PXR and HNF4 in HepaRG cells blocked the PXR ligand-mediated down-regulation of OCT1 expression. The mutation of HNF4 and USF1 (E-box) responsive elements reversed the PXR-mediated inhibition in gene reporter assays. Chromatin immunoprecipitation assays indicated that PXR activation sequestrates the SRC-1 coactivator from the HNF4 response element and E-box of the OCT1 promoter. Consistent with these findings, exogenous overexpression of the SRC-1, but not the PGC1 coactivator, relieved the PXR-mediated repression of OCT1 transactivation. Conclusions and ImplicationsPXR ligands reduced the HNF4-mediated and USF-mediated transactivation of OCT1 gene expression by competing for SRC-1 and decreased delivery of a model OCT1 substrate into hepatocytes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Nutrition & Dietetics

Vitamin K - sources, physiological role, kinetics, deficiency, detection, therapeutic use, and toxicity

Premysl Mladenka, Katerina Macakova, Lenka Kujovska Krcmova, Lenka Javorska, Kristyna Mrstna, Alejandro Carazo, Michele Protti, Fernando Remiao, Lucie Novakova

Summary: Vitamin K is not only involved in blood coagulation, but also in the maturation of proteins and physiological processes in bones. Research has suggested a possible link between vitamin K and the prevention of osteoporosis and cardiovascular diseases, but current knowledge is insufficient to make a decisive conclusion.

NUTRITION REVIEWS (2022)

Article Toxicology

Expression dynamics of pregnane X receptor-controlled genes in 3D primary human hepatocyte spheroids

Tomas Smutny, Veronika Bernhauerova, Lucie Smutna, Jurjen Duintjer Tebbens, Petr Pavek

Summary: This study utilized 3D PHHs to investigate the time-expression profiles of PXR-controlled genes during rifampicin treatment, revealing diverse expression patterns among different genes, some of which were influenced by rifampicin concentration. The results highlight the importance of long-term time-expression profiling in 3D PHHs for studying PXR target genes.

ARCHIVES OF TOXICOLOGY (2022)

Article Biochemistry & Molecular Biology

Comparison of Antiplatelet Effects of Phenol Derivatives in Humans

Marcel Hrubsa, Raul Alva, Mst Shamima Parvin, Katerina Macakova, Jana Karlickova, Jaka Fadraersada, Lukas Konecny, Monika Moravcova, Alejandro Carazo, Premysl Mladenka

Summary: Flavonoids have positive cardiovascular effects, and one of its metabolites, 4-methylcatechol, is a potent antiplatelet compound. In this study, the activity of 22 compounds, including 4-methylcatechol and its derivatives, were compared. Results showed that 17 compounds were highly active in inhibiting platelet aggregation, with 7 of them having an IC50 below 3 mu M. These compounds showed no toxicity to erythrocytes or significant effects on blood coagulation.

BIOMOLECULES (2022)

Article Chemistry, Medicinal

Screening of Synthetic Heterocyclic Compounds as Antiplatelet Drugs

Marcel Hrubsa, Khondekar Nurjamal, Alejandro Carazo, Nayana Nayek, Jana Karlickova, Lenka Applova, Indrajit Karmakar, Shamima Parvin, Jaka Fadraersada, Katerina Macakova, Premysl Mladenka, Goutam Brahmachari

Summary: In this study, the antiplatelet and anticoagulation properties of selected compounds were examined. Four out of 34 tested compounds showed equal or greater activity than the standard antiplatelet drug ASA. These compounds achieved their effects through antagonism at thromboxane receptors. The most active compound, 2-N, was 4-5 times more potent than ASA and holds promise for the development of novel antiplatelet drugs.

MEDICINAL CHEMISTRY (2022)

Article Food Science & Technology

Can Isoquinoline Alkaloids Affect Platelet Aggregation in Whole Human Blood?

Mst Shamima Parvin, Marcel Hrubsa, Jaka Fadraersada, Alejandro Carazo, Jana Karlickova, Lucie Cahlikova, Jakub Chlebek, Katerina Macakova, Premysl Mladenka

Summary: Isoquinoline alkaloids exhibit antiplatelet effects mainly at high concentrations, and bulbocapnine is a promising antiplatelet molecule.

TOXINS (2022)

Article Biochemical Research Methods

Preparation, In Vitro Affinity, and In Vivo Biodistribution of Receptor-Specific 68Ga-Labeled Peptides Targeting Vascular Endothelial Growth Factor Receptors

Pavel Barta, Rajamanikkam Kamaraj, Monika Kucharova, Zbynek Novy, Milos Petrik, Katerina Bendova, Marian Hajduch, Petr Pavek, Frantisek Trejtnar

Summary: As angiogenesis plays a crucial role in tumor growth and metastasis, it is important to target the vascular endothelial growth factor (VEGF) and its receptors (VEGFR-1 and VEGFR-2) for diagnostic and therapeutic purposes. In this study, two peptides labeled with PET emitters were prepared and tested as new imaging agents for tumor angiogenesis. The results showed that both peptides had good binding affinity to VEGFRs in cancer cells and exhibited potential for imaging.

BIOCONJUGATE CHEMISTRY (2022)

Review Hematology

Sex-Related Differences in Platelet Aggregation: A Literature Review Supplemented with Local Data from a Group of Generally Healthy Individuals

Alejandro Carazo, Marcel Hrubsa, Lukas Konecny, Pavel Skorepa, Marketa Paclikova, Frantisek Musil, Jana Karlickova, Lenka Javorska, Katerina Matousova, Lenka Kujovska Krcmova, Mst Shamima Parvin, Alena Smahelova, Vladimir Blaha, Premysl Mladenka

Summary: The process of platelet aggregation is influenced by factors such as sex and age. A literature review and a local study found sex-related differences in platelet aggregation, with women showing higher aggregation responses to certain agonists and lower benefit from inhibitors. Age also affects the aggregatory responses to different triggers, and further studies are needed to understand the biological importance of these differences.

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2023)

Meeting Abstract Toxicology

Toxicity of simple catechols and their interaction with estrogen receptor

R. Alva Gallegos, A. Carazo, P. Mladenka

TOXICOLOGY LETTERS (2022)

Article Environmental Sciences

The effects of bisphenols on the cardiovascular system ex vivo and in vivo

Vaclav Tvrdy, Patricia Dias, Iveta Nejmanova, Alejandro Carazo, Eduard Jirkovsky, Jana Pourova, Jaka Fadraersada, Monika Moravcova, Lucija Peterlin Masic, Marija Sollner Dolenc, Premysl Mladenka

Summary: The human population is regularly exposed to bisphenols, which are potentially toxic. This study aimed to test the effects of 14 bisphenols on the cardiovascular system and compare their effects in different settings. Most of the tested bisphenols could relax rat aorta, but their potency varied significantly.

CHEMOSPHERE (2023)

Article Nutrition & Dietetics

The Antiplatelet Effect of 4-Methylcatechol in a Real Population Sample and Determination of the Mechanism of Action

Marcel Hrubsa, Lukas Konecny, Marketa Paclikova, Mst Shamima Parvin, Pavel Skorepa, Frantisek Musil, Jana Karlickova, Lenka Javorska, Katerina Matousova, Lenka Kujovska Krcmova, Alejandro Carazo, Alena Smahelova, Vladimir Blaha, Premysl Mladenka

Summary: A polyphenol-rich diet has positive effects on cardiovascular health, and metabolites formed by human microbiota could be responsible for this effect. 4-MC, a small phenolic metabolite, was shown to be more potent than acetylsalicylic acid in reducing platelet aggregation, and the mechanism of its action was identified as interference with the coupling of cyclooxygenase and thromboxane synthase.

NUTRIENTS (2022)

Article Chemistry, Medicinal

SC-560 and mofezolac isosteres as new potent COX-1 selective inhibitors with antiplatelet effect

Miroslav Sisa, Lukas Konecny, Veronika Temml, Alejandro Carazo, Premysl Mladenka, Premysl Landa

Summary: In this study, a set of compounds structurally mimicking selective COX-1 inhibitors were designed and synthesized. The newly synthesized compounds exhibited remarkable selectivity and activity in enzymatic in vitro assays, with compound 10a showing comparable activity to SC-560 and even greater selectivity. Cell-based antiplatelet assays further confirmed this activity.

ARCHIV DER PHARMAZIE (2023)

Article Environmental Sciences

Toxicity overview of endocrine disrupting chemicals interacting in vitro with the oestrogen receptor

Raul Alva-Gallegos, Alejandro Carazo, Premysl Mladenka

Summary: This review aims to summarize the available knowledge on products derived from human industrial activity and other xenobiotics that interact with the estrogen receptor (ER). These chemicals, known as endocrine disruptors, can affect various physiological processes involving ER. However, most of the studies focus on individual compound testing, lacking in vivo models and assessments of xenobiotic combinations which better resemble real circumstances.

ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2023)

Article Chemistry, Medicinal

Improving the antimicrobial activity of old antibacterial drug mafenide: Schiff bases and their bioactivity targeting resistant pathogens

Martin Kratky, Klara Konecna, Adela Simkova, Ondrej Jandourek, Jana Maixnerova, Jirina Stolarikova, Marcela Vejsova, Barbora Voxova, Frantisek Trejtnar, Jarmila Vinsova

Summary: Twenty-one mafenide-based compounds were synthesized and tested for antimicrobial activity, showing promising efficacy against various pathogens including superbugs. Most imines of mafenide were bactericidal and retained activity against drug-resistant strains. The most promising drug candidates have iodinated salicylidene and 5-nitrofuran/thiophene-methylidene scaffolds.

FUTURE MEDICINAL CHEMISTRY (2023)

Article Nutrition & Dietetics

The Effect of 4-Methylcatechol on Platelets in Familial Hypercholesterolemic Patients Treated with Lipid Apheresis and/or Proprotein Convertase Subtilisin Kexin 9 Monoclonal Antibodies

Lukas Konecny, Marcel Hrubsa, Jana Karlickova, Alejandro Carazo, Lenka Javorska, Katerina Matousova, Lenka Kujovska Krcmova, Alena Smahelova, Vladimir Blaha, Milan Blaha, Premysl Mladenka

Summary: This study analyzed the antiplatelet effect of 4-MC in FH patients and compared its impact on two FH treatment modalities. The results showed that 4-MC had a stronger inhibitory effect on collagen-induced platelet aggregation in FH patients compared to the healthy control group. The study also found that apheresis improved the inhibitory effect of 4-MC on platelet aggregation, and patients treated with apheresis and pretreated with 4-MC had lower platelet aggregability compared to those solely treated with PCKS9Ab. This study confirmed the suitability of 4-MC as a promising antiplatelet agent and demonstrated its effect in patients with a genetic metabolic disease for the first time.

NUTRIENTS (2023)

暂无数据